High Impact Training to Patients With Prostate Cancer and Bone Metastases — HIP  

Prostate Cancer Clinical Trial

Official title: High Impact Training to Patients With Prostate Cancer and Bone Metastases

Status Recruiting

Clinical Trial Summary

HIP is a randomized controlled trial. The aim is investigate the effect, safety and feasibility of brief, high-impact exercise targeting bones in patients with prostate cancer and bone metastases. Furthermore, to investigate the effects of the intervention on bone status (bone mineral density) and body composition, physical function and performance, patient reported quality-of-life outcomes, falls and hospitalizations.

Clinical Trial Description

Participants assigned to the intervention group will participate in a 32-week, twice-weekly, 30-minute, supervised HIP program at the hospital in Herlev, Denmark. To ensure a safe transition to high-intensity exercise, the first eight weeks of the intervention includes self-bodyweight and low-impact variations with a focus on getting used to use weight training equipment and gradually learning the movement patterns of the HIP exercises. All participants should be able to perform the four basic exercises of the intervention within two months. The resistance exercises (deadlift, overhead press, and squats) will be performed in five sets of five repetitions for the remaining intervention period, maintaining an intensity of > 80% to 85% of 1 repetition maximum (RM). ;

Related Conditions & MeSH terms

• Neoplasm Metastasis
• Prostate Cancer
• Prostatic Neoplasms

• NCT number: NCT06259279
• Study type: Interventional
• Source: Copenhagen University Hospital at Herlev
• Contact: Anne-Mette Ragle, PhD student
• Phone: +4527128044
• Email: anne-mette.ragle@regionh.dk
• Status: Recruiting
• Phase: N/A
• Start date: February 6, 2024
• Completion date: December 31, 2026